Find a Program
Find a Lab
Message from the Chief
Patient Documentary
Rock musician Pat Spurgeon recounts his battle with kidney failure and treatment by UCSF transplant surgeon Sang-Mo Kang in a recent documentary.
Transplant Video Library
View videos of lectures pertaining to transplantation given by some of the world's top experts on the subject.
Make a Gift
A gift to the Department of Surgery helps us discover new treatments and cures.
Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients
Official Title:
A Phase 2, Multicenter, Open-Label, Active Comparator-Controlled, Extension Trial To Evaluate The Long-Term Safety And Efficacy Of CP-690,550 In Renal Allograft RecipientsBasic Trial Information
| Phase | Type | Age | Sponsor | Protocol IDs | Status |
|---|---|---|---|---|---|
| Phase 2 | Interventional | 18 - 70 Years | Pfizer |
A3921050 NCT00658359 |
Active, but closed to enrollment |
Study Design:
Prevention, Open Label, Parallel Assignment, Safety/Efficacy StudyPrincipal Investigator
Flavio Vincenti, M.D.
Professor of Clinical Medicine
Division of Nephrology
Departments of Medicine and Surgery
Trial Summary
This is a study that will follow transplant patients from Study A3921030 to monitor for long
term safety, tolerability and efficacy for 2 additional years. Patients will continue their
study medications that were previously assigned.
Eligibility
Inclusion Criteria:
- Subjects who successfully completed Study A3921030
Exclusion Criteria:
- Subjects who are on the waiting list for a second kidney transplant or any non-renal
organ transplants
Important
Final eligibility is determined by the health professionals conducting the trial and the protocol approved by the Committee on Human Resources (CHR) at the University of California, San Francisco (UCSF). The Patient Consent Form for this trial is available upon request. For more information about this trial, please see the full posting at ClinicalTrials.gov.
For More Information
For questions about this trial or eligibility, contact:
Clarina Mendoza
(415) 353-8380
Clarina.Mendoza@ucsfmedctr.org